IP Library Granted Patent US 9,688,979
Granted Patent B2
US 9,688,979 · App. 14/895,628 · Granted Jun 27, 2017

Biomolecule drying process for long-term storage

Inventors: Anke Pierik (Eindhoven, NL); Henk Van Damme (Eindhoven, NL); Martijn Van Zelst (Eindhoven, NL); Rene Bakker (Eindhoven, NL); Pieter De Bokx (Eindhoven, NL)
Assignee: BIOCARTIS NV
C12N9/96
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,688,979
App. No.
14/895,628
Granted
Jun 27, 2017
Kind
B2
Abstract

The present invention relates to a method for producing a storable dry composition of biomolecule. First a composition is dispensed on a surface. The composition comprises at least a biomolecule, at least a liquid volatile component, at least a polysaccharide being designed for forming together with the at least a biomolecule and a part of the at least a liquid volatile component a matrix displaying a glass transition temperature Tg. Secondly, at least a part of the liquid volatile component is evaporated by adjusting the temperature of said composition to allow the formation of the matrix. Said evaporation step is initiated at an initial temperature T 1 , and finished up at a final temperature T 2 , said final temperature T 2 being above said initial temperature T 1.

Claims (24)

1. A method for producing a storable dry composition of biomolecule, comprising:

(a) Dispensing at least a composition on a surface, the composition comprising:

(i) at least a biomolecule,

(ii) at least a liquid volatile component,

(iii) at least a polysaccharide being designed for forming together with the at least a biomolecule and a part of the at least a liquid volatile component a matrix displaying a glass transition temperature Tg,

(b) Evaporating at least a part of the at least a liquid volatile component by adjusting a temperature of said composition to allow formation of the matrix,

wherein step (b) is initiated at an initial temperature T 1 , and finished up at a final temperature T 2 , said final temperature T 2 being above said initial temperature T 1 .

2. A method according to claim 1 , wherein the initial temperature T 1 and final temperature T 2 are above the glass transition temperature Tg.

3. A method according to claim 1 , wherein a difference between the initial temperature T 1 and the glass transition temperature Tg and a difference between the final temperature T 2 and the glass transition temperature Tg remain constant and positive.

4. A method according to claim 1 , wherein the initial temperature T 1 is maintained between about 30° C. and about 50° C. during 30 minutes, and the final temperature T 2 is maintained between about 60° C. and about 90° C. during 30 minutes.

5. A method according to claim 1 , wherein step (b) is performed until a fraction of liquid volatile component of the composition reaches about 3%.

6. A method according to claim 1 , wherein step (b) is performed at initial temperature T 1 until a fraction of liquid volatile component of the composition reaches about 10%.

7. A method according to claim 1 , wherein the initial temperature T 1 is below 40° C.

8. A method according to claim 1 , wherein the final temperature T 2 is above 80° C.

9. A method according to claim 1 , wherein step (b) further makes use of a gas flow.

10. A method according to claim 1 , wherein the liquid volatile component is selected from a group comprising: water, alcohol, or a mixture thereof.

11. A method according to claim 1 , wherein the biomolecule is an enzyme for amplification reaction of nucleic acid.

12. A method according to claim 1 , wherein the composition comprises at least 0.1 M to 0.6 M of trehalose.

13. A method according to claim 1 , wherein the composition comprises at least 4.0 ug/uL to 8.0 ug/ul of Bovine Serum Albumin.

14. A method according to claim 1 , wherein the composition comprises at least 1.0% to 30.0% of glycerol.

15. A method according to claim 1 , wherein step (b) is performed until a fraction of liquid volatile component of the composition reaches about 2%.

16. A method according to claim 1 , wherein the composition comprises at least 0.15 M to 0.3 M of trehalose.

17. A method according to claim 1 , wherein the composition comprises at least 5.5 ug/uL to 6.5 ug/ul of Bovine Serum Albumin.

18. A method according to claim 1 , wherein the composition comprises at least 5.0% to 15.0% of glycerol.

Assignments (5)
SECURITY INTEREST Recorded Oct 31, 2023
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 065411/0175 →
SECURITY INTEREST Recorded Nov 4, 2022
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 061657/0976 →
SECURITY INTEREST Recorded Oct 28, 2022
From: BIOCARTIS NV
To: GLAS TRUST CORPORATION LIMITED
Reel/Frame 061583/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: PIERIK, ANKE; VAN DAMME, HENK; VAN ZELST, MARTIJN; BAKKER, RENE; DE BOKX, PIETER
To: BIOCARTIS SA
Reel/Frame 037200/0969 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: BIOCARTIS SA
To: BIOCARTIS NV
Reel/Frame 037201/0068 →
Priority Claims (1)
EP 13171437 · Jun 11, 2013 · regional
Continuity (1)
Related Publication 20160122744A1 · May 5, 2016